Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.


TSX:LABS - Post by User

Comment by 1hot-techwomanon Mar 26, 2024 6:44am
70 Views
Post# 35952332

RE:VIVO acqisition starting to pay off with Beacon GMBH

RE:VIVO acqisition starting to pay off with Beacon GMBH
mdjbrown wrote: Cansativa is no slouch in the German medical cannabis market.


"Beacon Medical GMBH, a wholly owned MediPharm subsidiary, holds numerous German GMP medical cannabis licenses to import, wholesale and distribute cannabis products.The subsidiary boasts 14 product approvals and distribution via German partners Adrex Pharma, Cansativa and Medical Pharma Resource."


100% !! There in a sweet spot :) $$$$
Future of LABS is starting to look good !!
Bring on Mar 27th :) 

<< Previous
Bullboard Posts
Next >>